{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:25:10Z","timestamp":1793496310048,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1044973"],"award-info":[{"award-number":["1044973"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100022031","name":"Tavistock Trust for Aphasia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022031","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001798","name":"Edith Cowan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Treatment fidelity is inconsistently reported in aphasia research, contributing to uncertainty about the effectiveness of types of aphasia therapy following stroke. We outline the processes and outcomes of treatment fidelity monitoring in a pre-specified secondary analysis of the VERSE trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>VERSE was a 3-arm, single-blinded RCT with a 12-week primary endpoint comparing Usual Care (UC) to two higher intensity treatments: Usual Care-Plus (UC-Plus) and VERSE, a prescribed intervention. Primary outcome results were previously reported. This secondary analysis focused on treatment fidelity. Video-recorded treatment sessions in the higher intensity study arms were evaluated for treatment adherence and treatment differentiation. Treatment components were evaluated using a pre-determined fidelity checklist. Primary outcome: prescribed amount of therapy time (minutes); secondary outcomes: (i) adherence to therapy protocol (%) and (ii) treatment differentiation between control and high intensity groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two hundred forty-six participants were randomised to Usual Care (<jats:italic>n<\/jats:italic>=81), Usual Care-Plus (<jats:italic>n<\/jats:italic>=82), and VERSE (<jats:italic>n<\/jats:italic>=83). One hundred thirty-five (82%) participants in higher intensity intervention arms received the minimum prescribed therapy minutes. From 10,805 (UC 7787; UC-Plus 1450; VERSE 1568) service events, 431 treatment protocol deviations were noted in 114 participants. Four hundred thirty-seven videos were evaluated. The VERSE therapists achieved over 84% adherence to key protocol elements. Higher stroke and aphasia severity, older age, and being in the UC-Plus group predicted more treatment deviations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found high levels of treatment adherence and differentiation between the intervention arms, providing greater confidence interpreting our results. The comprehensive systems for intervention fidelity monitoring and reporting in this trial make an important contribution to aphasia research and, we argue, should set a new standard for future aphasia studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ACTRN <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=364551&amp;isReview=true\">12613000776707<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06433-3","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:12:57Z","timestamp":1655381577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment fidelity monitoring, reporting and findings in a complex aphasia intervention trial: a substudy of the Very Early Rehabilitation in SpEech (VERSE) trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-1295","authenticated-orcid":false,"given":"Erin","family":"Godecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda L.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Ellery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Cadilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"2","key":"6433_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1177\/0269216317717369","volume":"32","author":"K Ang","year":"2018","unstructured":"Ang K, Hepgul N, Gao W, Higginson IJ. Strategies used in improving and assessing the level of reporting of implementation fidelity in randomised controlled trials of palliative care complex interventions: a systematic review. Palliat Med. 2018;32(2):500\u201316.","journal-title":"Palliat Med"},{"issue":"1","key":"6433_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cpr.2010.09.007","volume":"31","author":"RE Gearing","year":"2011","unstructured":"Gearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011;31(1):79\u201388.","journal-title":"Clin Psychol Rev"},{"key":"6433_CR3","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. Br Med J. 2014;348:g1687.","journal-title":"Br Med J"},{"key":"6433_CR4","doi-asserted-by":"publisher","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. https:\/\/doi.org\/10.1136\/bmj.c869.","DOI":"10.1136\/bmj.c869"},{"issue":"5","key":"6433_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/0278-6133.23.5.443","volume":"23","author":"AJ Bellg","year":"2004","unstructured":"Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004;23(5):443\u201351.","journal-title":"Health Psychol"},{"issue":"s1","key":"6433_CR6","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1111\/j.1752-7325.2011.00233.x","volume":"71","author":"B Borrelli","year":"2011","unstructured":"Borrelli B. The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials. J Public Health Dent. 2011;71(s1):S52\u201363.","journal-title":"J Public Health Dent"},{"issue":"4","key":"6433_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/clipsy.bpi045","volume":"12","author":"F Perepletchikova","year":"2005","unstructured":"Perepletchikova F, Kazdin AE. Treatment integrity and therapeutic change: issues and research recommendations. Clin Psychol Sci Pract. 2005;12(4):365\u201383.","journal-title":"Clin Psychol Sci Pract"},{"issue":"3-6","key":"6433_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10833196.2016.1261237","volume":"21","author":"O O\u2019Shea","year":"2016","unstructured":"O\u2019Shea O, McCormack R, Bradley J, O\u2019Neill B. Fidelity review: a scoping review of the methods used to evaluate treatment fidelity in behavioural change interventions. Phys Ther Rev. 2016;21(3-6):207\u201314.","journal-title":"Phys Ther Rev"},{"issue":"4","key":"6433_CR9","first-page":"1","volume":"36","author":"LT Dipper","year":"2021","unstructured":"Dipper LT, Franklin S, de Aguiar V, Baumgaertner A, Brady M, Best W, et al. An umbrella review of aphasia intervention description in research: the AsPIRE project. Aphasiology. 2021;36(4):1\u201326.","journal-title":"Aphasiology."},{"issue":"2","key":"6433_CR10","first-page":"S279","volume":"22","author":"J Hinckley","year":"2013","unstructured":"Hinckley J, Douglas NF. Treatment fidelity: its importance and reported frequency in aphasia treatment studies. Am J Speech-Language Pathol. 2013;22(2):S279\u2013S84.","journal-title":"Am J Speech-Language Pathol"},{"issue":"7","key":"6433_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/02687038.2019.1576442","volume":"33","author":"E Brogan","year":"2019","unstructured":"Brogan E, Ciccone N, Godecke E. Treatment fidelity in aphasia randomised controlled trials. Aphasiology. 2019;33(7):759\u201379.","journal-title":"Aphasiology"},{"issue":"1s","key":"6433_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1044\/2019_AJSLP-CAC48-18-0234","volume":"29","author":"J Hickin","year":"2020","unstructured":"Hickin J, Cruice M, Dipper L. A systematically conducted scoping review of the evidence and fidelity of treatments for verb deficits in aphasia: verb-in-isolation treatments. Am J Speech-Language Pathol. 2020;29(1s):530\u201359.","journal-title":"Am J Speech-Language Pathol"},{"issue":"1S","key":"6433_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1044\/2019_AJSLP-CAC48-18-0227","volume":"29","author":"EL Conlon","year":"2020","unstructured":"Conlon EL, Braun EJ, Babbitt EM, Cherney LR. Treatment fidelity procedures for an aphasia intervention within a randomized controlled trial: design, feasibility, and results. Am J Speech-Language Pathol. 2020;29(1S):412\u201324.","journal-title":"Am J Speech-Language Pathol"},{"issue":"5","key":"6433_CR14","first-page":"e023560","volume":"9","author":"M Carragher","year":"2019","unstructured":"Carragher M, Ryan B, Worrall L, Thomas S, Rose M, Simmons-Mackie N, et al. Fidelity protocol for the action success knowledge (ASK) trial: a psychosocial intervention administered by speech and language therapists to prevent depression in people with post-stroke aphasia. Br Med J Open. 2019;9(5):e023560.","journal-title":"Br Med J Open"},{"issue":"sup1","key":"6433_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02687038.2018.1489120","volume":"32","author":"N Behn","year":"2018","unstructured":"Behn N, Hilari K, Marshall J, Simpson A, Northcott S, Thomas S, et al. SUpporting well-being through PEeR-befriending (SUPERB) trial: an exploration of fidelity in peer-befriending for people with aphasia. Aphasiology. 2018;32(sup1):21\u20133.","journal-title":"Aphasiology."},{"issue":"1","key":"6433_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1044\/2019_AJSLP-19-00126","volume":"29","author":"LA Spell","year":"2020","unstructured":"Spell LA, Richardson JD, Basilakos A, Stark BC, Teklehaimanot A, Hillis AE, et al. Developing, implementing, and improving assessment and treatment fidelity in clinical aphasia research. Am J Speech-Language Pathol. 2020;29(1):286\u201398.","journal-title":"Am J Speech-Language Pathol"},{"issue":"0","key":"6433_CR17","first-page":"174749302096192","volume":"0","author":"E Godecke","year":"2020","unstructured":"Godecke E, Armstrong E, Rai T, Ciccone N, Rose ML, Middleton S, et al. A randomized control trial of intensive aphasia therapy after acute stroke: the very early rehabilitation for SpEech (VERSE) study. Int J Stroke. 2020;0(0):1747493020961926.","journal-title":"Int J Stroke"},{"issue":"3","key":"6433_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","volume":"67","author":"J McCambridge","year":"2014","unstructured":"McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014;67(3):267\u201377.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"6433_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"5","key":"6433_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1037\/0022-006X.73.5.852","volume":"73","author":"B Borrelli","year":"2005","unstructured":"Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005;73(5):852\u201360.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"6433_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"10","key":"6433_CR22","first-page":"1","volume":"34","author":"E Brogan","year":"2020","unstructured":"Brogan E, Ciccone N, Godecke E. An exploration of aphasia therapy dosage in the first six months of stroke recovery. Neuropsychol Rehabil. 2020;34(10):1\u201335.","journal-title":"Neuropsychol Rehabil."},{"issue":"10","key":"6433_CR23","first-page":"1","volume":"6","author":"E Brogan","year":"2020","unstructured":"Brogan E, Godecke E, Ciccone N. Behind the therapy door: what is \u201cusual care\u201d aphasia therapy in acute stroke management? Aphasiology. 2020;6(10):1\u201323.","journal-title":"Aphasiology."},{"issue":"1148","key":"6433_CR24","first-page":"1291","volume":"10","author":"E Dalton","year":"2019","unstructured":"Dalton E, Churilov L, Lannin NA, Corbett D, Hayward KS. Dose articulation in preclinical and clinical stroke recovery: refining a discovery research pipeline and presenting a scoping review protocol. Front Neurol. 2019;10(1148):1291\u2013313.","journal-title":"Front Neurol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06433-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06433-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06433-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:23:22Z","timestamp":1655382202000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06433-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6433"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06433-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"25 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by hospital ethics committees and all participants gave written informed consent using aphasia friendly consent processes.This study had Nationals Ethics approval via National Mutual Acceptance through The Austin Hospital (HREC13\/Austin\/101). All sites had site-specific agreements ethics approval based on the National Mutual Acceptance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as individual data not used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}